Want to join the conversation?
$MKC 2Q15 Call – Gordon, CFO: We expect our cost reduction & pricing activity to continue to improve gross profit margin. We expect gross profit margin for FY15 to be comparable to FY14, rather than up slightly. As percentage of net sales, our SG&A expense declined 60BP;& special charges of $19MM in 2Q15 related to additional actions planned EMEA.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)